Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism.

Zhou Q, Lin M, Feng X, Ma F, Zhu Y, Liu X, Qu C, Sui H, Sun B, Zhu A, Zhang H, Huang H, Gao Z, Zhao Y, Sun J, Bai Y, Jin J, Hong X, Zou C, Zhang Z
J Exp Med. 2020 Aug 3;217(8). pii: 151816. doi: 10.1084/jem.20191779. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.